Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 14/20 | 0.45 |
| ▸ | RARB | P10826 | 1/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9509387 | 0.93 | RARB (0.46) | ACACBRARBS1PR1S1PR3FFAR1 | |
| SCHEMBL9512446 | 0.91 | RARB (0.51) | ACACBRARBS1PR1S1PR3FFAR1 | |
| SCHEMBL9508758 | 0.91 | ACACB (0.48) | ACACBRARBS1PR1S1PR3MAPT | |
| SCHEMBL9512375 | 0.91 | S1PR1 (0.48) | ACACBRARBS1PR1S1PR3FFAR1 | |
| SCHEMBL9511505 | 0.90 | RARB (0.53) | ACACBRARBS1PR1S1PR3FFAR1 | |
| SCHEMBL9510170 | 0.90 | RARB (0.53) | ACACBRARBS1PR1S1PR3FFAR1 | |
| SCHEMBL9511326 | 0.90 | MAOB (0.43) | RARBS1PR1S1PR3FFAR1 | |
| SCHEMBL9512486 | 0.90 | ACACB (0.41) | ACACBFFAR1FFAR4 | |
| SCHEMBL9509310 | 0.89 | RARB (0.48) | ACACBRARBS1PR1S1PR3L3MBTL1 | |
| SCHEMBL17614861 | 0.87 | RARB (0.43) | RARBS1PR1S1PR3FFAR1FFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0308438-B1 | LIQUID CRYSTAL PHASE CONTAINING TOLANES | MERCK PATENT GmbH (DE) | 1993-09-29 | — | — | EP | disclosed |